ArticleProceedings of the National Academy of Sciences of the United States of America2023

Targeting the lipid kinase PIKfyve upregulates surface expression of MHC class I to augment cancer immunotherapy.

Yi Bao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.